RICHARD JOHN BUCALA, MD
Osteopathic Medicine in New Haven, CT
License number
Connecticut 040329
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
800 Howard Ave Yale BLDG PHYSICIANS, New Haven, CT 06519
Phone
(203) 785-2140
(203) 785-6414 (Fax)
(203) 785-7998
(203) 785-6414 (Fax)
(203) 785-7998
Professional information
See more information about RICHARD JOHN BUCALA at trustoria.com
Dr. Richard J Bucala, New Haven CT - MD (Doctor of Medicine)
Dr. Richard J Bucala, New Haven CT - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
1 Gilbert St SUITE S0420, New Haven 06519
800 Howard Ave, New Haven 06519
(203) 785-2140 (Phone), (203) 785-6414 (Fax)
YALE UNIVERSITY SCHOOL OF MEDICINE
789 Howard Ave SUITE 3RD, New Haven 06519
(203) 785-4629 (Phone), (203) 785-7273 (Fax)
800 Howard Ave, New Haven 06519
(203) 785-2140 (Phone), (203) 785-6414 (Fax)
YALE UNIVERSITY SCHOOL OF MEDICINE
789 Howard Ave SUITE 3RD, New Haven 06519
(203) 785-4629 (Phone), (203) 785-7273 (Fax)
Certifications:
Internal Medicine, 2003, Rheumatology, 2004
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Weill Cornell Medical College
Graduated: 1986
Brigham and Womens Hospital
Hosp Spec Surg
Weill Cornell Medical College
Graduated: 1986
Brigham and Womens Hospital
Hosp Spec Surg
Richard John Bucala, New Haven CT
Richard John Bucala, New Haven CT
Specialties:
Internal Medicine, Rheumatology, Infectious Disease, Cardiovascular Disease
Work:
Yale Rheumatology
800 Howard Ave, New Haven, CT 06519
800 Howard Ave, New Haven, CT 06519
Education:
Cornell University (1986)
Compositions And Methods For The Modulation Of Detrusor Activity
Compositions And Methods For The Modulation Of Detrusor Activity
US Patent:
2008008, Apr 17, 2008
Filed:
Jul 3, 2007
Appl. No.:
11/825253
Inventors:
George Kuchel - Avon CT, US
Richard Bucala - New Haven CT, US
Richard Bucala - New Haven CT, US
International Classification:
A61K 31/42, A61K 31/70, A61K 38/02, A61K 39/395, A61P 13/00, C07H 21/02, C12Q 1/68
US Classification:
424130100, 514002000, 514378000, 514043000, 536024100
Abstract:
The invention relates generally to methods for treating and/or preventing bladder disorders. In certain embodiments the invention comprises methods for the treatment and/or prevention of a bladder disorder comprising administering an effective amount of a therapeutic agent that decreases the expression, release or biological activity of macrophage migration inhibition factor (MIF) to a subject in need thereof. In other aspects the invention relates to a method for diagnosing bladder disease and/or bladder disease severity comprising screening for a MIF gene or MIF receptor gene polymorphism or expression level.